In addition, obesity-related gut dysbiosis can exacerbate systemic and local inflammation, partly through altered bile acid metabolism and disruption of farnesoid X receptor (FXR) signaling, thereby contributing to a pro-tumorigenic microenvironment (43). The gene discussed is NR1H4; the disease is obesity disorder.